MTOR and neoplasm: An in vivo study using xenograft models of ovarian cancer revealed that everolimus inhibited tumor growth, angiogenesis, and production of ascites, suggesting the potential of mTOR inhibitors in the treatment of women with ovarian cancer [9, 98].